{"entity":{"id":"journal-of-experimental-and-clinical-cancer-research","kind":"journal","name":"Journal of experimental & clinical cancer research","aka":["Journal of experimental & clinical cancer research : CR","J Exp Clin Cancer Res","JECCR"],"tldr":"An Italian-rooted open access journal for bench-to-bedside cancer research, from tumour models to early clinical studies. Read by translational cancer biologists and clinician scientists.","summary":"The Journal of Experimental & Clinical Cancer Research describes itself as an online peer-reviewed journal publishing original research papers, reviews and commentaries in cancer research from bench to bedside, seeking to bridge laboratory discoveries with the understanding, prevention, diagnosis and treatment of cancer. It is the official journal of the Regina Elena National Cancer Institute in Rome and is owned by the Association for the Promotion of International Tumor Studies; it is published by BMC, part of Springer Nature. Submissions are expected to report findings not previously published in the same model, studies performed in multiple cell lines, and conclusions that go beyond incremental results. NLM catalogues it from 1982 and notes that print issues ceased with volume 26 in 2007. The Directory of Open Access Journals lists it as fully open access since 2008 with anonymous peer review, an article processing charge, and CC BY and CC0 licences.","asOf":"2026-09-10","links":[{"label":"Homepage","url":"https://jeccr.biomedcentral.com/"},{"label":"NLM Catalog","url":"https://www.ncbi.nlm.nih.gov/nlmcatalog/8308647"},{"label":"DOAJ record","url":"https://doaj.org/toc/1756-9966"}],"tags":[],"related":["pubmed-europepmc"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"BMC (Springer Nature)","url":"https://jeccr.biomedcentral.com/","issn":"0392-9078","scope":"translational cancer research","access":"open-access","founded":1982,"matchNames":["J Exp Clin Cancer Res","Journal of experimental & clinical cancer research","Journal of Experimental & Clinical Cancer Research","Journal of Experimental and Clinical Cancer Research","JECCR"],"society":"Regina Elena National Cancer Institute"},"route":"/journals/journal-of-experimental-and-clinical-cancer-research/","neighbours":{"collection":[{"id":"pubmed-europepmc","kind":"collection","name":"PubMed & Europe PMC","route":"/collections/pubmed-europepmc/"}],"person":[{"id":"antonio-rosato","kind":"person","name":"Antonio Rosato","route":"/people/antonio-rosato/"},{"id":"christian-singer","kind":"person","name":"Christian Singer","route":"/people/christian-singer/"},{"id":"fan-daiming","kind":"person","name":"Fan Daiming","route":"/people/fan-daiming/"},{"id":"giovanni-blandino","kind":"person","name":"Giovanni Blandino","route":"/people/giovanni-blandino/"},{"id":"michal-mikula","kind":"person","name":"Michał Mikula","route":"/people/michal-mikula/"},{"id":"yu-jinming","kind":"person","name":"Yu Jinming","route":"/people/yu-jinming/"}],"paper":[{"id":"paper-ctla-4-colorectal-j-exp-clin-cancer-res-2019","kind":"paper","name":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","route":"/key-papers/paper-ctla-4-colorectal-j-exp-clin-cancer-res-2019/"},{"id":"paper-nct03476681-j-exp-clin-cancer-res-2023","kind":"paper","name":"First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors","route":"/key-papers/paper-nct03476681-j-exp-clin-cancer-res-2023/"}],"institution":[{"id":"regina-elena-rome","kind":"institution","name":"IRCCS Regina Elena National Cancer Institute","route":"/institutions/regina-elena-rome/"}]}}